8-K
filed February 9, 2023, 6:59 PM ET
ticker BRKR
CIK 0001109354
earnings
confidence high
sentiment positive
materiality 0.80
Bruker Q4 non-GAAP EPS $0.74 (+25% YoY); FY23 organic growth guidance 8-10%
BRUKER CORP
2022-FY EPS reported
$1.99
revenue$2,530,700,000
- Q4 revenues $708.4M (+3.6% reported, +8.9% organic); GAAP EPS $0.66 vs $0.50.
- FY22 revenues $2.531B (+4.7% reported, +10.2% organic); non-GAAP EPS $2.34 (+11.4%).
- FY23 guidance: revenue $2.81-2.86B (8-10% organic); non-GAAP EPS $2.52-2.57 (8-10% growth).
- BSI organic growth 9.5% (FY); BEST organic growth 17.4%; non-GAAP op margin expanded to 20.0%.
- Management cites double-digit organic bookings growth and accelerated investments in proteomics.
Key facts
Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
BRUKER CORP reported the three months ended December 31, 2022 results: revenue $708.4 million, EPS $0.66.
- Period
- the three months ended December 31, 2022
- Revenue
- $708.4 million
- EPS
- $0.66
- Result
- reported results
Exact text from the filing
9 – Financial Statements and Exhibits --- EX-99.1 (EX-99.1) --- EX-99.1 Exhibit 99.1 Bruker Reports Fourth Quarter and Fiscal Year 2022 Financial Results • Q4 2022 revenues $708.4 million, up 3.6% year-over-year (yoy); organic revenue growth of 8.9% • Q4 2022 GAAP EPS $0.66; non-GAAP EPS $0.74, up 25.4% yoy • FY 2022 revenues $2.531 billion, up 4.7% yoy; organic
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
BRUKER CORP reported FY 2023 results: revenue $2.81 to $2.86 billion, EPS $2.52 to $2.57. Guidance initiated.
- Period
- FY 2023
- Revenue
- $2.81 to $2.86 billion
- EPS
- $2.52 to $2.57
- Guidance
- initiated
- Result
- guidance update
Exact text from the filing
For FY 2023, Bruker expects revenue of $2.81 to $2.86 billion, or 11% to 13% year-over-year reported revenue growth
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
BRUKER CORP reported the year ended December 31, 2022 results: revenue $2.531 billion, EPS $1.99.
- Period
- the year ended December 31, 2022
- Revenue
- $2.531 billion
- EPS
- $1.99
- Result
- reported results
Exact text from the filing
• Q4 2022 revenues $708.4 million, up 3.6% year-over-year (yoy); organic revenue growth of 8.9% • Q4 2022 GAAP EPS $0.66; non-GAAP EPS $0.74, up 25.4% yoy • FY 2022 revenues $2.531 billion, up 4.7% yoy; organic revenue growth of 10.2% • FY 2022 GAAP EPS $1.99; non-GAAP EPS $2.34, up 11.4% yoy • Bruker expects FY 2023 organic revenue growth of 8% to 10% yoy
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.